Senate Roll Call 103

119th Congress · Session 2 · April 23, 2026

A vote on a proposed change to the bill

A vote on one change, not on the bill. A bill can collect dozens of these, and losing one does not stop it.

What was being voted on

119-SAMDT-5336 — To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.

SA 5336, submitted by Mr. Wyden, aims to add a section to title III of S. Con. Res. 33. The purpose is to create a deficit-neutral reserve fund regarding the duties of the Comptroller General of the United States. This amendment would allow the Chairman of the Senate Committee on the Budget to adjust budgetary levels and the pay-as-you-go ledger for legislation reported by the Senate Committee on Homeland Security and Governmental Affairs.

The Senate recorded this as
On the Amendment S.Amdt. 5336 to S.Con.Res. 33 (No short title on file)
To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.
Result: Amendment Rejected
Needed a simple majority — more than half of those voting.
Yea: 48Nay: 50Not Voting: 2100 members
PartyYeaNayPresentNot Voting
Democrat D44001
Independent I2000
Republican R25001
How each member voted (100)
48 yea, 50 nay, 2 not voting